Policlinico di Bari — Bari

Public research footprint of Policlinico di Bari, compiled from the ClinicalTrials.gov public registry.

265

Registered studies

106

Active

Recruiting now

108

Completed

Stopped or withdrawn

Most-studied conditions

Measles-Mumps-Rubella+Chickenpox Vaccine · Neovascular Age-related Macular Degeneration (nAMD) · Arthritis, Psoriatic · Relapsed/Refractory Multiple Myeloma

Recently updated registry entries

NCT07742644 — A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps… (Not Yet Recruiting)
NCT05407636 — Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (Active Not Recruiting)
NCT07204275 — Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Policlinico di Bari?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.